Navigation Links
New approach for surgery patients cuts hospital stays and costs
Date:4/24/2014

on the surgical team's preferences.

Under traditional perioperative care, patients who experience pain, stress, immobilization, and postoperative constipation can remain in the hospital for 10 days or more, with complication rates of up to 48 percent. Such complications can be expensive, estimated at an average of $10,000.

Enhanced recovery after surgery (ERAS), which has gained favor in Europe but has not been widely used in the United States, aims to standardize perioperative care using procedures backed by scientific evidence that demonstrate their benefits.

In the Duke study, patients in the ERAS group were educated about what they should expect. Routine bowel preparation was not performed, and patients were allowed to drink clear fluids until 3 hours before their surgeries, notably a sports drink.

All of the ERAS patients received an epidural as well as non-opioid painkillers to reduce opioid side effects such as nausea, vomiting, constipation, urinary retention and drowsiness. They then underwent general anesthesia. After surgery, the patients transitioned to oral acetaminophen or other non-steroidal anti-inflammatory drugs, plus oral opioids, if necessary, after about 72 hours. Patients were also encouraged to drink liquids and get out of bed on the day of surgery, and for at least six hours every subsequent day.

"We have shown that providing care within an ERAS pathway, we are increasing the quality of care for patients while at the same time reducing complications and medical costs," said co-author Timothy Miller, assistant professor of anesthesiology at Duke. "I believe that going forward, enhanced recovery care could become the new standard for best practice."

Gan said the researchers saved costs for about 85 percent of the ERAS patients, at about $2,000 per patient. He said the ERAS approach could be used for numerous surgeries; it has been expanded at Duke University Hospital to include bladder, p
'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches
2. New approach may help manage the most troubling symptoms of dementia, lessen use of drugs
3. Benaroya Research Institute evaluates immunology approach to blocking breast cancer
4. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
5. New guidelines employ a team approach to autism diagnosis and care
6. New approach to prostate cancer screening needed
7. REACT clinical trial supports new approach of accelerated treatment for Crohns disease
8. Researchers find novel approach for controlling deadly C. difficile infections
9. Novel biomarker approach suggests new avenues to improve schizophrenia disease management
10. Craig Stephens as a Marketing Specialist for Plastic Surgeons Offers a Decidedly Unique Approach to Surgeons for Developing Their Online Presence
11. OHSU researchers develop new drug approach that could lead to cures for wide range of diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 2014 (HealthDay News) -- People with diabetes face a number ... keep you healthy, an expert says. "With the holidays ... with the events, the family you,ll be visiting and all ... of Diabetes Educators, said in an association news release. "By ... healthy." One idea is to make a healthy eating ...
(Date:11/28/2014)... BambooFlooringChina.com has been recognized as a ... the business has announced its new strand woven ... discount on these new models. , Based on the ... without carpenter machines involved. It is crafted on strand ... for do-it-yourselfers without hard work on installation, also available ...
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 Dr. ... cosmetic dermatologists , announced the addition of Dr. Bridgit ... Nolan joins the practice after having completed her dermatology ... Medicine. , Dr. Walder invited Dr. Nolan ... in medicine, surgery and cosmetic dermatology. Not only does ...
(Date:11/28/2014)... Dr. Andrew Campbell, one of the ... expansion of Quintessa Aesthetic Center into a third location ... W307 N1497 Golf Road in Suite 200 and will ... the new Delafield location will offer a variety of ... Botox, filler injectables , micro laser peels, chemical ...
(Date:11/28/2014)... Melbourne, Australia (PRWEB) November 28, 2014 ... has undergone healthy growth over the past five ... population's increasing acceptance of therapies that are either ... conventional treatments. According to IBISWorld industry analyst David ... the ageing population and growing private health insurance ...
Breaking Medicine News(10 mins):Health News:Holiday Eating Tips for People With Diabetes 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4
... chiefs have said “negative” to allegations that a perceived problem ... will upset the immunization// schedule of thousands of babies and ... of the Health IT initiative by the Government, to track ... problem, it is estimated that nearly 3,000 children would find ...
... to be believed neural transplants could be used to ... for a number of people came from a group ... provide improvement and a period of stability in Huntington's ... bad thing to happen to anyone. It is a ...
... scientists are of the opinion that women are in a ... that was conducted using rodents they found that female rodents ... shed light on health differences between males and females. ... 120 rats and measured in them what is known as ...
... to disclose the results of study findings with participants ... published in the April 1, 2006 issue of CANCER,// ... that such disclosures may actually do more harm than ... ,Maurie Markman, M.D., of the University of ...
... Claudia Twiby, eighteen months old was kept alive with a Berlin ... ,Four weeks later she received a new donated heart ... Lansdale, 32, and Shaun Twiby, 42. ,Claudia was only ... at London's Great Ormond Street Hospital, which first carried out the ...
... European regulators have not given the green signal to a ... . This is a step retrograde to a budding industry ... animals , ,GTC Biotherapeutics, proponents of this drug, ... the verdict came about only on the basis of a ...
Cached Medicine News:Health News:Men Are Less Capable Of Handling Stress Than Women – New Stud 2Health News:Regulators Object Drug Produced from Genetically Engineered Farm Animals 2
(Date:11/26/2014)... Nov. 26, 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced ... to raise approximately $3.3 million at a price of ... one institutional healthcare focused investor. Each unit consists of one ... share purchase warrant. Each whole warrant entitles the holder ... $0.30 for a period of five years from closing.  ...
(Date:11/26/2014)... 26, 2014  Cohen, Placitella & Roth, PC ... who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") ... from January 31, 2011 through November 2, 2014 ... certain of its officers and directors publically disseminated ... Sections 10(b) and 20(a) of the Securities Exchange ...
(Date:11/26/2014)... THE WOODLANDS, Texas , Nov. 26, 2014 ... LXRX ) today announced the completion of previously ... of $280.0 million.  After fees and estimated offering ... million from the transactions.  The transactions consisted of: ... shares of common stock, pursuant to a registration ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
... Tissue Oncology, Society held in Seattle, Washington demonstrates clinical ... single agent in patients with ... chemo-insensitive sarcomas, NEW YORK, Nov. ... preliminary data demonstrating the,tolerability and clinical activity of KRX-0401 (perifosine) in ...
... (ASX: PGL; Nasdaq: PGLA) today announced additional,data from the ... this,year. This data was presented at the 58th Annual ... Diseases in Boston, USA(1). As the Phase 2 ... data analysis described in this presentation was performed to,evaluate ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3
The PYRAMETRIX PLUS instrument system is the next generation in design for disc space preparation and removal....
CD HORIZON SEXTANT Rod Insertion System...
Kerrison (Micro) Laminectomy Rongeur. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 down-cutting, jaws 1 mm wide....
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
Medicine Products: